Application Nr Approved Date Route Status External Links
ANDA075511 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Famotidine Tablets Are Indicated In Adult And Pediatric Patients 40 Kg And Greater For The Treatment Of: Active Duodenal Ulcer (Du). Active Gastric Ulcer (Gu). Active Gastric Ulcer (Gu). Symptomatic Nonerosive Gastroesophageal Reflux Disease (Gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. Famotidine Tablets Are Indicated In Adults For The: Treatment Of Pathological Hypersecretory Conditions (E.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Duodenal Ulcer Recurrence. Famotidine Tablets Are A Histamine-2 (H2 ) Receptor Antagonist Indicated (1): In Adult And Pediatric Patients 40 Kg And Greater For The Treatment Of: Active Duodenal Ulcer (Du). Active Gastric Ulcer. Symptomatic Nonerosive Gastroesophageal Reflux Disease (Gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. In Adults For The: Treatment Of Pathological Hypersecretory Conditions (E.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Du Recurrence.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Famotidine FAMOTIDINE ZINC1530636

Comments